Related Experiment Video

Updated: Jul 5, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Challenges to the diagnosis, evaluation, treatment, and management of clustered cardiometabolic risk factors

George Bakris, Vivian Fonseca, JoAnne Foody

    Journal of the Cardiometabolic Syndrome
    |May 6, 2008
    PubMed

    Insights

    This expert panel addressed challenges in diagnosing and managing clustered cardiometabolic risk factors. Improving patient outcomes requires a comprehensive approach to these interconnected health issues.

    Area of Science:

    • Cardiology
    • Metabolic Diseases
    • Internal Medicine

    Background:

    • Clustered cardiometabolic risk factors present significant diagnostic and management challenges.
    • Effective treatment requires addressing the complex interplay of conditions like hypertension, dyslipidemia, and diabetes.

    Purpose of the Study:

    • To discuss current challenges in the diagnosis, evaluation, treatment, and management of clustered cardiometabolic risk factors.
    • To provide expert insights into optimizing patient care strategies for these interconnected conditions.

    Main Methods:

    • An expert panel discussion was convened on January 10, 2007.
    • The panel included leading physicians in cardiology and metabolic diseases.
    • Discussion focused on identifying and overcoming barriers to effective management.

    Main Results:

    • Key challenges identified include the complexity of diagnosis and the need for integrated treatment approaches.
    • Experts emphasized the importance of a multidisciplinary strategy for managing patients with multiple risk factors.
    • The discussion highlighted the need for improved patient education and adherence to treatment plans.

    Conclusions:

    • Addressing clustered cardiometabolic risk factors requires a multifaceted approach.
    • Enhanced collaboration among healthcare providers is crucial for optimal patient outcomes.
    • Continued research and guideline development are necessary to refine management strategies.

    Related Concept Videos

    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Type II Diabetes I: Introduction01:26

    Type II Diabetes I: Introduction

    Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...